Literature DB >> 28798245

Regadenoson cardiac stress test-induced stress cardiomyopathy.

Jagadeesh K Kalavakunta1, Dominika M Zoltowska2, Yashwant Agrawal2, Vishal Gupta1.   

Abstract

Takotsubo cardiomyopathy, also described as apical ballooning syndrome/stress-induced cardiomyopathy, imitates acute coronary syndrome and is usually related to a massive physiological or emotional stressor. We describe perhaps the first reported case to the best of our knowledge of a 55-year-old Caucasian woman who presented with congestive heart failure after having a regadenoson cardiac stress test a few hours prior to presentation to the hospital. Transthoracic echocardiogram revealed reduced heart function. She had normal coronaries on cardiac catheterisation, and left ventriculography confirmed apical ballooning syndrome. She underwent guideline-directed therapy, and heart function improved in the repeat echocardiogram along with clinical resolution of symptoms. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cardiovascular medicine; heart failure; interventional cardiology

Mesh:

Substances:

Year:  2017        PMID: 28798245      PMCID: PMC5624024          DOI: 10.1136/bcr-2017-221217

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Stress cardiomyopathy associated with vasodilator stress testing.

Authors:  William Morgan; Fadi Hage
Journal:  J Nucl Cardiol       Date:  2020-02-12       Impact factor: 5.952

2.  Regadenoson Cardiac Stress Test-Induced Takotsubo Cardiomyopathy: A Case Report.

Authors:  Saira Farid; Muhammad Ahsan; Hector M Garcia-Garcia
Journal:  Cureus       Date:  2020-05-07

3.  Inverted Takotsubo Syndrome With HELLP Syndrome: A Case Report.

Authors:  Paul Gabarre; Pablo Ruiz; Camille Chenevier-Gobeaux; Etienne Charpentier; Laurie Soulat-Dufour; Ariel Cohen; Laurence Monnier-Cholley; Lotfi Chemali; Hélène François; Mathieu Kerneis; Guillaume Lefèvre; Mathieu Boissan
Journal:  Front Cardiovasc Med       Date:  2022-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.